Financials
- Market Capitalization 6.71 M
- Employee 41
- Founded 2007
- CEO N/A
- Website www.bioatla.com
- Headquarter Delaware, United States
- FIGI BBG00Y6GBT61
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.56
Fiyat/satışlar oranı
-180.52
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4908 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.63 USD | +3.16% | +13.19% | +0.62% | -15.10% | 7.01 M USD | ||
| 4915 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 2.38 USD | -1.65% | -28.74% | -37.37% | -56.88% | 6.83 M USD | ||
| 4923 | XBIO Xenetic Biosciences, Inc. - Common Stock | 3.01 USD | +5.99% | +5.99% | -7.10% | -18.65% | 6.90 M USD | ||
| 4925 | APM Aptorum Group Limited - Class A Ordinary Shares | 0.81 USD | 0.00% | +3.85% | -4.71% | -13.83% | 6.60 M USD |